Topical Tirbanibulin, a Dual Src Kinase and Tubulin Polymerization Inhibitor, for the Treatment of Plaque-Type Psoriasis: Phase I Results.
- DOI
- 10.3390/pharmaceutics14102159
- Published
- 2022 Oct 11
- Container
- Pharmaceutics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/pharmaceutics14102159,
title = {Topical Tirbanibulin, a Dual Src Kinase and Tubulin Polymerization Inhibitor, for the Treatment of Plaque-Type Psoriasis: Phase I Results.},
author = {Hong JB and Wu PY and Qin A and Huang YW and Tseng KC and Lai CY and Chan WK and Fang J and Cutler DL and Tsai TF},
year = {2022},
journal = {Pharmaceutics},
doi = {10.3390/pharmaceutics14102159},
url = {https://doi.org/10.3390/pharmaceutics14102159}
}RIS
TY - JOUR TI - Topical Tirbanibulin, a Dual Src Kinase and Tubulin Polymerization Inhibitor, for the Treatment of Plaque-Type Psoriasis: Phase I Results. AU - Hong JB AU - Wu PY AU - Qin A AU - Huang YW AU - Tseng KC AU - Lai CY AU - Chan WK AU - Fang J AU - Cutler DL AU - Tsai TF PY - 2022 JO - Pharmaceutics DO - 10.3390/pharmaceutics14102159 UR - https://doi.org/10.3390/pharmaceutics14102159 ER -
APA
JB, H., PY, W., A, Q., YW, H., KC, T., CY, L., WK, C., J, F., DL, C., & TF, T. (2022). Topical Tirbanibulin, a Dual Src Kinase and Tubulin Polymerization Inhibitor, for the Treatment of Plaque-Type Psoriasis: Phase I Results.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics14102159
Source records
- pubmed · retrieved 2026-09-26T14:51:49.161Z